Purdue University
251
25
33
181
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
3.6%
9 terminated/withdrawn out of 251 trials
95.3%
+8.8% vs industry average
5%
12 trials in Phase 3/4
14%
25 of 181 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (251)
Slowly Digestible Carbohydrates for GLP-1 Secretion
Role: lead
A1-Free vs. Conventional Milk Metabolic Response Study
Role: lead
RINEW Randomized Controlled Trial 7-year Follow-up
Role: collaborator
Nutrition for Precision Health, Powered by the All of Us
Role: collaborator
Emergency Department-Substance Use Screening, Motivational Interviewing and Active Referral Targeting Substance Use Disorder and Overdose Prevention
Role: lead
Real World Assessment of Resistance Breathing Device
Role: collaborator
Reducing Alcohol Exposed Pregnancies
Role: collaborator
e-HERO: Ending the HIV Epidemic in Rural Oklahoma
Role: collaborator
More Individualized Care: Assessment and Recovery Through Engagement
Role: collaborator
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
Role: collaborator
Molecular Studies and Clinical Correlations in Human Prostatic Disease
Role: collaborator
Vagus Nerve Response in Gastroparesis Patients
Role: collaborator
Effect of Stimulation on the Vagus Nerve
Role: collaborator
Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve
Role: collaborator
Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Motion
Role: collaborator
Nourish Pilot & CoDesign Study
Role: collaborator
Ondansetron for the Management of Atrial Fibrillation
Role: collaborator
Imatinib for Pain in Sickle Cell Anemia
Role: collaborator
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
Role: lead
Leg Heat Therapy in Peripheral Artery Disease
Role: collaborator